Literature DB >> 18627661

Oral HPV complications in HIV-infected patients.

Jennifer E Cameron1, Michael E Hagensee.   

Abstract

Human papillomavirus (HPV) infection and disease, including that of the oral cavity, has not dramatically declined since the introduction of potent combination therapy to control HIV. Two manifestations of HPV in the oral cavity that may be on the rise are HPV-32-associated oral warts and HPV-16-associated oral cancers. A current research focus is the natural history of HPV infections in the oral cavity. A better understanding of the natural history of oral HPV infections could lead to improved diagnosis and treatment for oral HPV complications in HIV-positive patients.

Entities:  

Mesh:

Year:  2008        PMID: 18627661     DOI: 10.1007/s11904-008-0020-6

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  41 in total

1.  Oral warts rise dramatically with use of new agents in HIV.

Authors:  J Leigh
Journal:  HIV Clin       Date:  2000

2.  Effect of highly active antiretroviral therapy on frequency of oral warts.

Authors:  D Greenspan; A J Canchola; L A MacPhail; B Cheikh; J S Greenspan
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

3.  Definitive radiotherapy for squamous cell carcinoma of the base of tongue.

Authors:  William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; John W Werning; Douglas B Villaret
Journal:  Am J Clin Oncol       Date:  2006-02       Impact factor: 2.339

4.  Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.

Authors:  Bengt Göran Hansson; Kerstin Rosenquist; Annika Antonsson; Johan Wennerberg; Elsy-Britt Schildt; Anna Bladström; Gunilla Andersson
Journal:  Acta Otolaryngol       Date:  2005-12       Impact factor: 1.494

5.  Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus.

Authors:  F Coutlée; A M Trottier; G Ghattas; R Leduc; E Toma; G Sanche; I Rodrigues; B Turmel; G Allaire; P Ghadirian
Journal:  Sex Transm Dis       Date:  1997-01       Impact factor: 2.830

6.  The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults.

Authors:  Jennifer E Cameron; Donald Mercante; Megan O'Brien; Ann M Gaffga; Janet E Leigh; Paul L Fidel; Michael E Hagensee
Journal:  Sex Transm Dis       Date:  2005-11       Impact factor: 2.830

7.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

8.  Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.

Authors:  S M Schwartz; J R Daling; K A Shera; M M Madeleine; B McKnight; D A Galloway; P L Porter; J K McDougall
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

9.  Novel HPV types present in oral papillomatous lesions from patients with HIV infection.

Authors:  C Völter; Y He; H Delius; A Roy-Burman; J S Greenspan; D Greenspan; E M de Villiers
Journal:  Int J Cancer       Date:  1996-05-16       Impact factor: 7.396

10.  Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum.

Authors:  I Arany; S K Tyring
Journal:  Int J STD AIDS       Date:  1998-05       Impact factor: 1.359

View more
  10 in total

Review 1.  Epidermodysplasia verruciformis in an HIV-infected man: a case report and review of the literature.

Authors:  Amit Kaushal; Shane Silver; Ken Kasper; Alberto Severini; Sate Hamza; Yoav Keynan
Journal:  Top Antivir Med       Date:  2012-12

2.  Mechanisms of viral infections associated with HIV: workshop 2B.

Authors:  S M Tugizov; J Y Webster-Cyriaque; S Syrianen; A Chattopadyay; H Sroussi; L Zhang; A Kaushal
Journal:  Adv Dent Res       Date:  2011-04

3.  Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.

Authors:  Katia Muller; Julie Kazimiroff; Mahnaz Fatahzadeh; Richard V Smith; Mauricio Wiltz; Jacqueline Polanco; Robert M Grossberg; Thomas J Belbin; Howard D Strickler; Robert D Burk; Nicolas F Schlecht
Journal:  J Infect Dis       Date:  2015-02-13       Impact factor: 5.226

4.  Human Papillomavirus Prevalence in Oral and Oropharyngeal Rinse and Gargle Specimens of Dental Patients and of an HIV-Positive Cohort from Pretoria, South Africa.

Authors:  Neil H Wood; Koketso S Makua; Ramokone L Lebelo; Nina Redzic; Ina Benoy; Olivier M Vanderveken; Johannes Bogers
Journal:  Adv Virol       Date:  2020-08-26

Review 5.  Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma.

Authors:  Liviu Feller; Neil H Wood; Razia A G Khammissa; Johan Lemmer
Journal:  Head Face Med       Date:  2010-07-15       Impact factor: 2.151

6.  Natural history of anal vs oral HPV infection in HIV-infected men and women.

Authors:  Daniel C Beachler; Gypsyamber D'Souza; Elizabeth A Sugar; Wiehong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2013-04-17       Impact factor: 5.226

Review 7.  An update on oral human papillomavirus infection.

Authors:  Ankit H Bharti; Kiran Chotaliya; Y S Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2013-07

8.  Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes.

Authors:  Joan A Phelan; William R Abrams; Robert G Norman; Yihong Li; Maura Laverty; Patricia M Corby; Jason Nembhard; Dinah Neri; Cheryl A Barber; Judith A Aberg; Gene S Fisch; Michael A Poles; Daniel Malamud
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

9.  Epithelial maturation and molecular biology of oral HPV.

Authors:  Liviu Feller; Razia Ag Khammissa; Neil H Wood; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2009-11-25       Impact factor: 2.965

10.  Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial.

Authors:  Ashita S Batavia; Rode Secours; Patrice Espinosa; Marc Antoine Jean Juste; Patrice Severe; Jean William Pape; Daniel W Fitzgerald
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.